[PE] Lorlatinib 25 mg

By: Fressia Trejos Aguero📍 Costa RicaClosed

Key Information

ReferenceGB-2026XE-000029-0001102102
DeadlineOct 27, 2026 12:00 AM
CategoryAdvertising & Media
Competition TypeICB
Funding SourceFunded
CountryCosta Rica
AddressCosta Rica
PublishedOct 22, 2026

Description

[PE] Lorlatinib 25 mgResponsible for publication, objection management and opening: Fressia Trejos Aguero

Full details are available after unlocking this tender.

Generated from Tender Access Hub · Oct 28, 2026 8:59 AM